February 17, 2015 / 2:12 PM / in 3 years

BUZZ-Oncolytics Biotech Inc: Orphan status for pancreatic cancer drug

** Canadian drug developer’s shares up 25.4 pct at 65 cents premarket

** FDA grants orphan drug designation for company’s pancreatic cancer drug candidate

** Drug already received status for ovarian cancer

** Orphan drug status granted to drugs developed to treat rare diseases; gives drug developer incentives, including 7-year marketing exclusivity

** Up to Friday’s close, stock had fallen more than 68 percent in past 12 months

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below